Answers are grounded in this paper and cite their sources.
Derivatives of muramyl dipeptide (MDP) are considered as immunostimulants and adjuvants in the immunotherapy of cancer and infections. The interest in these compounds is mainly related to a high variety of their structure and biological properties. Here, we describe the synthesis and biological activity of several recently developed classes of MDP analogues. We also report potential of these analogues in the treatment of cancer and infectious diseases in experimental systems and cancer patients.
No takes yet. Share an insight, caveat, or question.
Dzierzbicka et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: